In the latest trading session, Moderna (MRNA) closed at $51.38, marking a -1.89% move from the previous day. This change lagged the S&P 500's daily loss of 1.51%. On the other hand, the Dow registered ...

By Roshan Thomas and Yantoultra Ngui March 20 (Reuters) - Five Chinese companies launched Hong Kong share sales on Friday ...

This clinical-stage biotech develops therapies for serious immunological diseases, with a focus on late-stage biologic candidates.

Mayo Clinic in Arizona has two campuses. The largest is in north Phoenix, where a big expansion is underway. Here's what to ...

The hefty funding will support a U.S. and China-based startup that’s amassed a pipeline of nearly 20 drugs and formed two lucrative partnerships with Sanofi.

Despite world-class AI-biotech research, a Nobel Prize-winning protein design lab and proximity to global AI expertise, Washington's life sciences sector is still learning to tell its story.

This clinical-stage biotech develops precision therapies for genetically defined diseases, targeting rare cancers and ...

This week on "The Readout LOUD," a conversation with biotech "godfather" Stelios Papadapolous live from #STATBreakthrough.

The Motley Fool reports that biotech stocks surged in 2025, driven by FDA approvals and a doubling of longevity investment to ...

Engineered tissue could eventually be used for children born with gaps in their alimentary canal, or for adults whose muscles ...

AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...

Sironax, a global clinical-stage biotechnology company developing transformative therapies for neurodegenerative, inflammatory and immunological, metabolic, and rare diseases, today announced its ...